Difference between revisions of "Team:TCU Taiwan/Project/Overview"
Line 24: | Line 24: | ||
<br> | <br> | ||
<h1> | <h1> | ||
− | <table width=" | + | <table width="80%" align="center"> |
<tr> | <tr> | ||
<td align="center"><span style="font-family:AR DESTINE,AR BONNIE,Comic Sans MS;"><font size="8"><font-weight: 900;>AMP. coli</font></span></td> | <td align="center"><span style="font-family:AR DESTINE,AR BONNIE,Comic Sans MS;"><font size="8"><font-weight: 900;>AMP. coli</font></span></td> | ||
</tr> | </tr> | ||
</table> | </table> | ||
− | |||
<table width="80%" align="center"> | <table width="80%" align="center"> | ||
<tr> | <tr> |
Revision as of 05:56, 12 July 2015
Antimicrobial peptides (AMPs), a peptide that have been proved to solve the rising problem of bacterial resistance. Our target is to develop it into a potential material of wound dressing.
|
Contact us tcutaiwan@gmail.com No.701, Sec. 3, Zhongyang Rd. Hualien 97004, Taiwan |